Labcorp looks to next earnings date, shares trade steadily on NYSE
29.06.2026 - 12:29:07 | ad-hoc-news.de
By Mark Bergmann, Earnings & Calendar desk. Reviewed prior to publication on 2026-06-29, 12:28.
Labcorp (US50540R4092) is on investor watch ahead of its next quarterly earnings update on the New York Stock Exchange. The healthcare diagnostics group sits in a sector that has seen consistent activity, with peers such as Quest Diagnostics and Thermo Fisher shaping expectations for demand in testing and lab services.
What recent filings show
According to data compiled by MarketBeat, Labcorp shares last closed at 272.09 US dollars on the NYSE on 2026-06-26, with a small after-hours move reported shortly after the close. The same source highlights an insider transaction disclosure, with an executive selling a modest number of shares, a standard feature in large US healthcare groups.MarketBeat insider trading overview for Labcorp
Position in the healthcare peer group
Labcorp competes in the broad US diagnostics and laboratory services segment, where Quest Diagnostics and Thermo Fisher Scientific serve as key listed peers in the S&P 500 healthcare space. Market commentators frequently compare volume trends and margin resilience across these names when assessing the outlook for routine testing and specialized lab services.Reuters sector note on US diagnostics groups
More news and background on the Labcorp shares
All current articles, price data and regulatory filings on Labcorp are collected on the dedicated topic page and the company’s own investor relations site.
The business behind the stock
Labcorp generates revenue by providing clinical laboratory testing, drug development and diagnostic services to physicians, hospitals, pharmaceutical companies and patients. The company’s portfolio ranges from routine blood work and COVID-19 testing to more specialized oncology, genetics and women’s health diagnostics, anchoring its position in the US healthcare infrastructure.
Where the shares trade today
The Labcorp shares (US50540R4092) last traded on the NYSE at 272.09 US dollars as of 2026-06-26, 15:59 Eastern Time, according to MarketBeat. This level places the group firmly within the large-cap US healthcare cohort.
Key data on the Labcorp shares
- Company: Laboratory Corporation of America Holdings
- ISIN: US50540R4092
- WKN: 895308
- Ticker: LH
- Trading venue: NYSE
- Price (as of 2026-06-26, 15:59): 272.09 USD
- Market cap: 23.0 billion USD (as of 2026-06-26)
- Sector / industry: Health Care / Diagnostics & Research
- Index membership: S&P 500
- Next earnings date: not officially scheduled
This text is for informational purposes only and does not constitute investment advice, a recommendation or a solicitation to buy or sell any security. All data were compiled from sources believed to be reliable at the time of publication but may change without notice.
